IP Verse

Blueprint Medicines Corporation opposition analysis

COMPANY ANALYSIS

Latest patents of Blueprint Medicines Corporation opposed by its competitors

Patent:

Grant Date:

Sep 6, 2023

Title:

Crystalline Forms Of (S)-1-(4-Fluorophenyl)-1-(2-(4-(6-(1-Methyl-1H-Pyrazol-4-Yl)Pyrrolo[2,1-F][1,2,4]Triazin-4-Yl)Piperazinyl)-Pyrimidin-5-Yl)Ethan-1-Amine And Methods Of Making

Oppositions:

Latest patents of Blueprint Medicines Corporation opposed by its competitors

Patent Number	Grant Date	Title	Total Oppositions
EP3856341	Sep 6, 2023	Crystalline Forms Of (S)-1-(4-Fluorophenyl)-1-(2-(4-(6-(1-Methyl-1H-Pyrazol-4-Yl)Pyrrolo[2,1-F][1,2,4]Triazin-4-Yl)Piperazinyl)-Pyrimidin-5-Yl)Ethan-1-Amine And Methods Of Making	1

Competitors of Blueprint Medicines Corporation

TER MEER STEINMEISTER & PARTNER PATENTANWALTE MBB

Want to track Blueprint Medicines Corporation?

Feel free to send us a message here and we will get back to you